Antiretroviral therapy in pregnancy: a 2023 review of the literature
AN Goulding, K Meeks, L Shay, S Casey… - Current HIV/AIDS …, 2024 - Springer
Abstract Purpose of Review Selection of antiretroviral therapy during pregnancy must
consider maternal physiology and resulting pharmacokinetic changes in pregnancy …
consider maternal physiology and resulting pharmacokinetic changes in pregnancy …
Development and emerging trends of drug resistance mutations in HIV: a bibliometric analysis based on CiteSpace
X Chen, X Chen, Y Lai - Frontiers in Microbiology, 2024 - frontiersin.org
Background Antiretroviral therapy has led to AIDS being a chronic disease. Nevertheless,
the presence of constantly emerging drug resistance mutations poses a challenge to clinical …
the presence of constantly emerging drug resistance mutations poses a challenge to clinical …
[HTML][HTML] HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon
GF Nzengui-Nzengui, G Mourembou… - BMC Infectious …, 2024 - Springer
Introduction In 2022, the WHO reported that 29.8 million people around the world were living
with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25 375 people in …
with HIV (PLHIV) and receiving antiretroviral treatment (ART), including 25 375 people in …